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This work aims at reviewing the present state of the art when it comes to understanding the
pathophysiology of narcolepsy and the Kleine–Levin syndrome (KLS) from a neuroimaging
point of view.This work also aims at discussing future perspectives of functional neuroimag-
ing in these sleep disorders. We focus on functional magnetic resonance imaging (fMRI),
which is a technique for in vivo measurements of brain activation in neuronal circuitries
under healthy and pathological conditions. fMRI has significantly increased the knowledge
on the affected neuronal circuitries in narcolepsy and the Kleine–Levin syndrome. It has
been shown that narcolepsy is accompanied with disturbances of the emotional and the
closely related reward systems. In the Kleine Levin syndrome, fMRI has identified hyper-
activation of the thalamus as a potential biomarker that could be used in the diagnostic
procedure.The fMRI findings in both narcolepsy and the Kleine–Levin syndrome are in line
with previous structural and functional imaging studies. We conclude that fMRI in combi-
nation with multi-modal imaging can reveal important details about the pathophysiology in
narcolepsy and the Kleine–Levin syndrome. In the future, fMRI possibly gives opportunities
for diagnostic support and prediction of treatment response in individual patients.
Keywords: functional magnetic resonance imaging, narcolepsy, hypersomnia, Kleine–Levin syndrome, sleep,
ascending arousal system, hypothalamus, thalamus
1. INTRODUCTION
Narcolepsy and the Kleine–Levin syndrome (KLS), a specific form
of periodic idiopathic hypersomnia, are two different sleep disor-
ders characterized by excessive sleepiness. However, the temporal
course of the sleepiness and concomitant neurological symptoms
are different. Although, significant progress regarding the etiol-
ogy of KLS and especially narcolepsy has been made recently,
the pathophysiological mechanisms underlying the diversity of
symptoms in these disorders are not fully defined.
1.1. NARCOLEPSY: SYMPTOMS AND ETIOLOGY
Narcolepsy is characterized by excessive daytime sleepiness, noc-
turnal dysomnia, and cataplexy (1). The excessive daytime sleepi-
ness is manifested as abruptly impinging sleep attacks at inactivity.
Cataplexy is a sudden muscle weakness that often is initiated by
positive emotion and laughter. Other typical features are sleep
onset rapid eye movement (SOREM), hypnagogic hallucinations,
and/or vivid dreams. The etiology of narcolepsy is related to
hypocretin production in the hypothalamus (2, 3). Hypocretin
neurons stabilize sleep-wake states and loss of these neurons results
in an imbalance in the regulation of sleep and wakefulness, which
leads to narcolepsy (4). Hypocretins are also suggested to regulate
emotional processes, which could explain the phenomenon of
emotionally triggered cataplexy in narcolepsy (5).
An up to 25-fold increase in the childhood incidence of nar-
colepsy has recently been described in relation to the 2009 H1N1
pandemic vaccination campaign in Finland and Sweden (6–9).
In China, an increase in narcolepsy was observed after the H1N1
influenza itself, independent of H1N1 vaccination (10). A combi-
nation of genetic and environmental factors has been hypothesized
to be involved in the pathogenic mechanisms of narcolepsy, where
an autoimmune process triggered by seasonal Streptocoocus, H1N1
infection, and following AS03-adjuvanted pH1N1 influenza vacci-
nation is leading to hypothalamic destruction with loss of hypocre-
tin neurons (11). Very recently, it was discovered that narcolepsy
patients have T cells that are reactive to hypocretin, supporting
that narcolepsy is an autoimmune disease (12). The autoimmune
hypothesis is also supported by recent findings of reduced levels
of beta-amyloid in CSF in narcolepsy (13).
1.2. KLS: SYMPTOMS AND ETIOLOGY
KLS is another disorder characterized by excessive sleepiness, but
with different characteristics as compared to narcolepsy. KLS
is characterized by extremely long sleep periods or prolonged
night-time sleep. These periods of excessive sleepiness typically
last about one to two weeks and recur several times a year (14, 15).
In contrast to narcolepsy, KLS is a relapsing disorder with mean
duration of 14 years. In addition to excessive sleepiness, the KLS
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patients also have cognitive (working memory, language), per-
ceptual (delusions, hallucinations), and behavioral disturbances
(binge eating, hypersexuality) during their sleep episodes. Between
sleep episodes, the patients have normal sleep and absence of
the other accompanying symptoms. However, persistent working
memory problems have been reported between sleep episodes (16)
as well as after relapse (17).
The etiology of KLS is to a large extent unknown and remains
a challenge. Hypothalamic abnormality has been suggested due to
the important function of the hypothalamus in sleep regulation.
Hypoperfusion or decreased metabolism have been observed in
the hypothalamus in a few cases (18–21), however, hormone and
hypocretin levels are usually normal. Interperiodic hypoperfusion
in cerebral blood flow (CBF) demonstrated by single photon emis-
sion tomography (SPECT) is also described in frontal and tempo-
ral regions (17, 22). In addition, several functional neuroimaging
studies have indicated complex involvement of thalamo-cortical
circuits in KLS (See Engström (23) and Arnulf et al. (24) for
reviews).
1.3. AIM
We aim to show if pathophysiological mechanisms in narcolepsy
and KLS could be revealed by in vivo measurements and visualiza-
tion of anatomical biomarkers of brain function. This will be done
by reviewing the functional magnetic resonance imaging (fMRI)
literature on narcolepsy and KLS. We will also discuss future pos-
sibilities to further investigate brain pathology in narcolepsy and
KLS using novel fMRI and multi-modal methods.
2. FUNCTIONAL MAGNETIC RESONANCE IMAGING
fMRI records the blood oxygen level dependent (BOLD) signal,
which is a response to neural activation in the brain. The BOLD
response reflects local changes in deoxygenated hemoglobin (Hb)
concentration as deoxygenated Hb has different magnetic prop-
erties compared to oxygenated Hb, this leads to a change in the
MR signal (25). The biophysical mechanisms behind the BOLD
response, however, remains elusive. Several models describing oxy-
gen metabolism and hemodynamics have been proposed (26).
Recent research suggests that neurotransmitters directly cause the
BOLD response via signaling pathways in glia cells (27).
Traditionally, the BOLD response in fMRI is measured as the
neurovascular response to cognitive tasks or sensory stimuli. Thus,
fMRI experiments consist of extrinsic stimuli presented to the
participant within pre-defined time intervals; so called fMRI par-
adigms. During image analysis, the correlation between the time
course of the paradigm and the time course of the BOLD response
is calculated (28). If there is a significant correlation between the
paradigm and the BOLD time course in a certain region of the
brain, this region is said to be activated by the task. The advantage
with task-related fMRI is that detected BOLD responses could
directly be related to a certain cognitive task or sensory stimu-
lus. On the other hand, the examination is of limited use when
experiments involve sleeping participants.
If active participation is unattainable or unwanted, examina-
tion during resting wakefulness or sleep without specific tasks or
stimuli is possible. This because brain regions that are involved
in cognitive tasks or respond to sensory stimuli display coherent
low frequency BOLD fluctuations also without any task or stim-
uli administered (29). This phenomenon was first discovered in
the so-called default mode network (DMN), which is consistently
more activated during resting control conditions compared to any
fMRI task. Later, it was discovered that DMN also show coherent
BOLD signal fluctuations when no tasks or stimuli were present
(30–33). It has now been shown that several other networks of
the brain, for example the executive and the salience networks,
also present coherent fluctuations during resting wakefulness. Fur-
thermore, combining fMRI with EEG, electrooculogram (EOG),
and/or video recordings provides excellent opportunities to study
event-related brain oscillations (34–36) and functional connectiv-
ity during different sleep-stages (37, 38). Thus, both spontaneous
and sleep-stage related brain oscillations can be studied using
fMRI.
3. fMRI IN NARCOLEPSY
fMRI studies in narcolepsy patients with cataplexy demonstrate
abnormal processing in the brain’s emotional networks. Two inde-
pendent studies in 10 and 12 narcolepsy patients, respectively, used
a similar paradigm with humorous and not humorous or neutral
pictures (39, 40). In both studies, the narcolepsy patients showed
increased BOLD responses to humorous stimuli in the amygdala,
nucleus accumbens, and the insula compared with control sub-
jects. However, the BOLD responses to humorous stimuli in the
hypothalamus were opposite in these two studies: Schwartz and
co-workers (40) found increased hypothalamic response in the
control group, whereas Reiss and co-workers (39) found increased
hypothalamic response in the narcolepsy group. In another study
on 14 narcolepsy–cataplexy patients, Ponz et al. (5) observed that
narcolepsy patients had abnormal activation in the reward system
using the monetary incentive delay task (MID). The MID task
evokes BOLD responses to the experience of monetary gains and
losses. In this study, the authors observed increased cortical activity
in the amygdala and the dorsal striatum for positive gaming out-
comes in narcolepsy patients compared to controls. In yet another
study, the same authors reported reduced activation in the amyg-
dala in narcolepsy–cataplexy during aversive conditioning (41). In
the latter study, the aversive conditioning was induced by a brief
painful electrical stimulation.
From these four previous fMRI studies, it can be concluded
that narcolepsy with cataplexy is associated with abnormal BOLD
responses in the emotional and the closely related reward systems.
It appears that positive stimulation is associated with increased
BOLD responses in the amygdala, whereas negative stimulation is
associated with decreased responses. However, the BOLD response
to humorous stimuli in the hypothalamus remains elusive since
two studies found contradictory results. Nevertheless, these fMRI
findings are in line with structural neuroimaging, which have
shown narcolepsy-related aberrations in brain structures, such
as the amygdala, nucleus accumbens, midbrain, thalamus, hip-
pocampus, and fronto-temporal cortical areas (42–45).
Only few fMRI studies have investigated the relation between
brain activation and pharmacological therapy in narcolepsy (46–
48). Because of the low number of subjects and the outdated
imaging techniques in the older studies, these results remain
inconclusive.
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4. fMRI IN KLS
During periods of hypersomnia, KLS patients are frequently
affected by cognitive disturbances, of which working memory
problems are common (14, 15). Our group has previously reported
that working memory dysfunction may persist between the peri-
ods of hypersomnia (17). The finding of working memory dys-
function in KLS was further investigated by fMRI aiming to
describe the neural networks involved (16, 49, 50). During fMRI,
KLS patients and healthy controls were administered the Dane-
man and Carpenter reading span task, which is a complex working
memory task (51). The task was designed with four difficulty lev-
els and data was analyzed for parametric responses to increased
cognitive demand.
During the complex working memory task, KLS patients show
hyperactivation in the left thalamus as compared to healthy con-
trols. They also show less activation in the anterior cingulate cortex
and adjacent medial prefrontal cortex (16). These results could be
reproduced in a larger patient group and also in patients who
returned for a second examination (23, 49, 50). An overview of
the results for the extended study, including 18 KLS patients and
18 controls, is shown in Figure 1. Furthermore, KLS patients had
lower working memory capacity; both in the task administered
during fMRI and in the standard version of the listening span task.
These findings demonstrate that KLS patients have deteriorated
working memory function that affects thalamo-cortical networks
also between periods of hypersomnia. A subsequent study aimed
to describe working memory function in KLS on a network level
by investigating the functional connectivity (49). KLS patients
seemed to have non-optimal recruitment of neural resources in
the executive network during task performance, and they also had
increased functional connectivity between the left thalamus and
the executive and salience networks, respectively.
The consistent findings of hyperactivation of the thalamus
during fMRI indicate a possible thalamic pathology in KLS. We
therefore measured the concentration of pathology biomarkers
using magnetic resonance spectroscopy (MRS) (50). However,
MRS data showed no difference between KLS patients and controls
regarding any of the investigated biomarkers. On the other hand,
there was a significant negative correlation between the level of
brain activation during working memory performance and the
concentration of N -acetylaspartate (NAA) in the left thalamus.
This finding indicates a possible neurodegenerative process in KLS
patients with high thalamic activation.
The most consistent fMRI finding in KLS is abnormal thal-
amic function (52). Thalamic abnormality is also reported from
SPECT studies investigating cerebral perfusion in KLS. Huang et al.
reported hypoperfusion of the left thalamus in 18 out of 30 KLS
patients and of the right thalamus in three patients (53). In contrast
to fMRI, which was performed in the asymptomatic state between
sleep episodes, hypoperfusion of the thalamus was reported in KLS
patients during sleep episodes (19, 54, 55). Thus, imaging thala-
mic function in individual patients could provide biomarkers of
KLS pathology. In a recent study, using binary logistic regression,
we found that fMRI of the thalamus and assessment of working
memory performance predicted KLS diagnosis with 80% accuracy
when comparing with healthy subjects (23).
5. FUTURE PERSPECTIVES: IMAGING BIOMARKERS OF
NARCOLEPSY AND KLS
5.1. ANATOMICAL BIOMARKERS OF BRAIN FUNCTION
By fMRI it is possible to identify the anatomical location of neural
entities that are involved in different aspects of brain function
related to narcolepsy and KLS and their concomitant symptoms,
as shown in the literature review. Here, in Figure 1, we visualize
thalamic hyperactivity in KLS during working memory perfor-
mance (16, 23, 49). We also show preliminary results of brain
activation in emotional (56) and sleep regulating networks (4)
in a patient with narcolepsy (Figure 2); results that are in agree-
ment with previous literature (5, 39–41). Thus, the dorsal branch
of the ascending arousal system including the thalamus is pre-
sumably affected in KLS and the ventral branch including the
hypothalamus in narcolepsy (Figure 2). Based on findings in the
literature, we argue that fMRI has the potential to image anatom-
ical biomarkers of brain function in narcolepsy and KLS, and
FIGURE 1 | Brain activation in Kleine–Levin syndrome (KLS)
during working memory performance. The orange areas show
typical working memory activation in the executive network in healthy
individuals. Pink areas show regions with hyperactivation in KLS
patients. The main finding of thalamic hyperactivation is marked with
a pink arrow. The white arrow marks areas within the orange
activation cluster in the anterior cingulate cortex and adjacent medial
prefrontal cortex where KLS patients had less activation compared to
the healthy control group. Data include 18 KLS patients and 18
matched controls (23).
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FIGURE 2 |The ascending arousal system involved in regulation
of sleep and wakefulness. (A)The figure is a schematic description
of the ventral (red) and dorsal (blue) pathways of the ascending
arousal system. BF=basal forebrain, Thal= thalamus, PAG=
periaqueductal gray, Raphe=Raphe nuclei, LC= locus coeruleus,
TEG= tegmentum, RF= reticular formation. (B). The figure shows
brain activation in one male narcolepsy patient during emotional
flanker task (57) in emotional and sleep regulating networks.
OFC= orbitofrontal cortex, vAIC= ventral anterior insular cortex,
mPFC=medial prefrontal cortex, PCC=posterior cingulate cortex,
PC=precuneus, Hyp=hypothalamus, Thal= thalamus,
dTEG=dorsal tegmentum.
possibly also in other disorders of pathological sleep. In KLS, it
has been shown that fMRI measures of thalamic activation com-
bined with working memory assessment could predict diagnosis
with high accuracy when comparing with healthy individuals (23).
Thus, fMRI in KLS could possibly be used as diagnostic aid. This
finding must, however, be validated by comparing fMRI in KLS
and other differential diagnosis. In narcolepsy, fMRI has been
used to investigate the relation between brain activation and phar-
macological therapy (46–48). Although results were promising,
they remain hypothetical until validated in larger patient groups.
Improved methods for data acquisition and analysis are necessary
to fully utilize the potential of fMRI for diagnosis and prediction
of treatment response in individual patients.
5.2. DYNAMIC BIOMARKERS OF BRAIN FUNCTION
Dynamic biomarkers describe the temporal courses of brain func-
tion in regions of interest or interactions within brain networks,
so called functional connectivity. Powerful methods for brain con-
nectivity assessment, such as dynamic causal modeling (DCM)
(58), reveal mechanisms of actions in brain networks. By DCM,
neural interactions between the thalamus and the prefrontal cor-
tex, and their modulation by working memory performance, can
be studied in KLS. In narcolepsy, DCM can be used to study
neural interactions between the hypothalamus and the amyg-
dala and their modulation by emotional processing. In previous
studies, it has been shown that DCM is powerful when investigat-
ing pharmacological treatment responses in the brain (59, 60). A
completely new approach to study brain dynamics is mechanistic
modeling of the event-related BOLD response using ordinary dif-
ferential equations (61). By this method it is possible to study the
underlying neurovascular dynamics of the BOLD response, e.g.,
neurotransmitter release and the effect of vasoactive agents (27).
5.3. MULTI-MODAL IMAGING
To further advance the understanding of brain function in nar-
colepsy and KLS, fMRI could preferentially be combined with
other imaging methods, so called multi-modal imaging. Positron
emission tomography (PET) has provided valuable information
about pathology in narcolepsy and KLS (62–65). The multitude
of imaging protocols for structural and functional imaging makes
MRI a multi-modal method itself. In MRI, quantitative relaxom-
etry (66) or diffusion tensor imaging (DTI) can give informa-
tion about pathological changes in brain microstructure. Thus,
these methods can be used to investigate possible microstruc-
ture changes in the thalamus in KLS or pathological white matter
integrity in the emotional system in narcolepsy. By magnetic
resonance spectroscopy (MRS), the concentration of different
metabolites in the brain has been measured in narcolepsy (67, 68).
Novel images sequences allow measurements of the absolute con-
centrations of the neurotransmitters GABA and glutamate (69).
Information about neurotransmitter levels could be used as input
in the mechanistic models discussed above (61), and brain GABA
concentration could be related to CSF orexin levels to further the
understanding of pathophysiology in narcolepsy.
Previous fMRI studies on narcolepsy and KLS were performed
during wakefulness. No fMRI studies have so far looked at sleep
and sleep dysfunction in these sleep disorders. By simultaneous
acquisition of fMRI and EEG data, it is possible to explore the
dynamics of brain function during different sleep-stages. Previ-
ous fMRI–EEG studies in healthy individuals show specific brain
activation patterns related to characteristic sleep-stages, such as
slow wave (SW) and rapid eye movement (REM) sleep, as well
as brain activity related to sleep spindles and K-complexes (34,
36–38). Thus, combined fMRI–EEG would certainly add impor-
tant information about the pathophysiology in narcolepsy and
KLS by investigating the typical SOREM sleep in narcolepsy or the
hypersomnic state in KLS in comparison to normal sleep.
5.4. ULTRA-HIGH RESOLUTION IMAGING OF BRAIN FUNCTION
While fMRI has revolutionized the understanding of the human
brain during the last 10 years, its spatial resolution, which today is
in the millimeter range, is far from what is possible, and its tempo-
ral resolution is much slower than the speed of neural processes.
Ultra-high field (UHF) MRI with magnetic field strengths above
7T would improve the sensitivity of fMRI dramatically. However,
when UHF-fMRI was introduced, there was a concern about
increased risk of susceptibility artifacts in regions adjacent to nasal
and oral cavities. Recent studies have now demonstrated improved
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detection of brain activation in ventral brain regions, such as the
amygdala, and also in subcortical structures (70, 71). Since the
amygdala is a key region of interest in narcolepsy and the ascend-
ing arousal system has important subcortical hubs (Figure 2), this
research indicates that it is possible to obtain more detailed infor-
mation about the brain function in areas related to sleep pathology
using UHF-fMRI.
6. CONCLUSION
By fMRI, it is possible to identify anatomical biomarkers of brain
function related to narcolepsy and KLS and their concomitant
symptoms. However, the clinical use of fMRI must be validated in
future studies. Novel fMRI and multi-modal methods that inves-
tigate the dynamics in brain networks involved in sleep regulation
should be explored for their potential to investigate pathological
sleep. Such technologies are necessary to fully utilize the poten-
tial of fMRI for diagnosis and prediction of treatment response in
individual patients.
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